Novocure
Novocure is an oncology firm that engages in the research, development and commercialization of therapeutics for treating solid tumor cancers.
Business Model:
Revenue: $542.6M
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Novocure Information
Geographic Data
Address: Grenville Street
City: Saint Helier
State: other
Zip: JE2 4UF
Country: JE
Financial Info
Stage:
post ipo debt
Raised Last:
$150M
Raised Total:$875M
Social
Metrics
1,432,449Website Global Rank
19,516Website Monthly Traffic
Twitter Followers
Description
Novocure is an oncology firm that engages in the research, development and commercialization of therapeutics for treating solid tumor cancers.
Contact Phone:
Contact Email:
Novocure went public on 10/9/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/9/2015
IPO Valuation:
$2B
Ticker Symbol:
NVCR
IPO Price:
$22/share
Amount Raised:
$165M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2009 | Venture Round | 4 | - |
Pfizer Venture Investments Johnson &a; Johnson Development Corporation Pfizer Index Ventures Pfizer Venture Investments Johnson &a; Johnson Development Corporation Pfizer Index Ventures |
10/2015 | IPO | $165M |
|
11/2020 | Post-IPO Debt | $575M | 11/2020 | Post-IPO Debt | 1 | $150M |
JP Morgan Chase JP Morgan Chase JP Morgan Chase JP Morgan Chase |
9/2020 | Post-IPO Debt | 1 | $15.5M |
Cybele Holdings Cybele Holdings |
2/2018 | Debt | 1 | $150M |
BioPharma Credit BioPharma Credit BioPharma Credit BioPharma Credit |
7/2017 | Post-IPO Equity | 1 | $13M |
Cybele Holdings Cybele Holdings |
1/2015 | Debt | $100M |
Pharmakon Advisors |
6/2000 | Equity | - | 6/2000 | Equity | - | 9/2009 | Venture Round | 4 | - |
Pfizer Venture Investments Johnson &a; Johnson Development Corporation Pfizer Index Ventures Pfizer Venture Investments Johnson &a; Johnson Development Corporation Pfizer Index Ventures |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
